erythromycin - CISMeF

Preferred Label : erythromycin;

MeSH definition : A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.;

MeSH synonym : erythromycin a;

CISMeF synonym : C, erythromycin;

MeSH hyponym : erycette; erythromycin phosphate; erythromycin lactate; ilotycin; T-Stat; erymax; Phosphate, Erythromycin; Lactate, Erythromycin; T Stat; TStat;

Related MeSH term : erythromycin C;

MeSH Related Number : 114-07-8 (Erythromycin); erythromycin phosphate; I8T8KU14X7;

Registry Number MeSH : 114-07-8;

Related CAS MeSH : I8T8KU14X7 (Erythromycin phosphate);

Wikipedia link : https://en.wikipedia.org/wiki/Erythromycin;

Codes EINECS : 204-040-1;

Is substance : O;

UNII : 63937KV33D;

InChIKey : ULGZDMOVFRHVEP-RWJQBGPGSA-N;

Details

Origin ID

D004917;

UMLS CUI

C0014806;

ATC code(s)
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin, combinations [ATC Code]
ATC code(s)
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Erythromycin poisoning (disorder) [SNOMED CT concept]
- Poisoning caused by erythromycin AND/OR other macrolide (disorder) [SNOMED CT concept]
- erythromycin [Substance BNPC]
Currated CISMeF NLP mapping
- Erythromycin [LOINC component]
- Erythromycin [ICD-11 Extension code]
- Erythromycin [SMS substance]
- Erythromycin [NCIt concept]
- Erythromycin (substance) [SNOMED CT concept]
- erythromycin [Artificial nutrition thesaurus concept]
- erythromycin, nos [SNOMED Notion]
False automatic mappings
- Accessory anterior naris (disorder) [SNOMED CT concept]
- Accessory urethra (disorder) [SNOMED CT concept]
- Amazona albifrons (organism) [SNOMED CT concept]
- Amino sugar (substance) [SNOMED CT concept]
- Angiectasia (morphologic abnormality) [SNOMED CT concept]
- Benzo fast scarlet stain (substance) [SNOMED CT concept]
- Biebrich scarlet stain (substance) [SNOMED CT concept]
- Bullous ichthyosiform erythroderma (disorder) [SNOMED CT concept]
- Choroidal effusion (disorder) [SNOMED CT concept]
- Craggy epididymis (finding) [SNOMED CT concept]
- Cylindrical dilatation (morphologic abnormality) [SNOMED CT concept]
- Elm pollen allergen (substance) [SNOMED CT concept]
- Fluid thrill in abdomen (finding) [SNOMED CT concept]
- Isolated lutropin deficiency (disorder) [SNOMED CT concept]
- Kalmia (organism) [SNOMED CT concept]
- Lack of ossification of tarsal bone (disorder) [SNOMED CT concept]
- Migraine with persistent visual aura (disorder) [SNOMED CT concept]
- Narrow nostril (finding) [SNOMED CT concept]
- Omental bursa structure (body structure) [SNOMED CT concept]
- Pustular eczema (disorder) [SNOMED CT concept]
- Queen palm pollen allergen (substance) [SNOMED CT concept]
- Saccular dilatation (morphologic abnormality) [SNOMED CT concept]
- Scleral staphyloma (disorder) [SNOMED CT concept]
- Senile angioma (disorder) [SNOMED CT concept]
- Serofibrinous effusion (morphologic abnormality) [SNOMED CT concept]
- Serosanguineous effusion (morphologic abnormality) [SNOMED CT concept]
- Spruce pollen allergen (substance) [SNOMED CT concept]
- Staphyloma posticum (disorder) [SNOMED CT concept]
- Structure of anterior naris (body structure) [SNOMED CT concept]
- Structure of buccal gingival crevice (body structure) [SNOMED CT concept]
- Structure of mesial gingival crevice (body structure) [SNOMED CT concept]
- Structure of triangular bone (body structure) [SNOMED CT concept]
- Takydromus (organism) [SNOMED CT concept]
- Vibratory tinnitus (finding) [SNOMED CT concept]
Indexing information
- S-adenosylmethionine-erythromycin O-methyltransferase [MeSH Supplementary Concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
- gastrointestinal agents [MeSH Descriptor]
- protein synthesis inhibitors [MeSH Descriptor]
Record concept(s)
- T-Stat [MeSH concept]
- erycette [MeSH concept]
- erymax [MeSH concept]
- erythromycin [MeSH concept]
- erythromycin C [MeSH concept]
- erythromycin lactate [MeSH concept]
- erythromycin phosphate [MeSH concept]
- ilotycin [MeSH concept]
Related MeSH Supplementary Concept(s)
- (8R,9S)-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A [MeSH Supplementary Concept]
- (8S)-8-hydroxyerythromycin-B [MeSH Supplementary Concept]
- (8S,9S)-8,9-anhydroerythromycin-B 6,9-hemiacetal-8,9-epoxide [MeSH Supplementary Concept]
- (N-methyl) erythromycin [MeSH Supplementary Concept]
- 10-dihydro-10-deoxo-11-azaerythromycin A [MeSH Supplementary Concept]
- 11-dehydroxy-9-deoxo-9-hydroxy-11-oxoerythromycin A [MeSH Supplementary Concept]
- 11-deoxy-11-(carboxy(3,4-dichlorophenethyl)amino)-3-O-(4-methyloxazolidin-2-one-3-yl)carbamoyl-5-O-(3'-N-desmethyl-3'-N-cyclopropylmethyl)desosaminyl-6-O-methylerythronolide A 11,12-(cyclic carbamate) [MeSH Supplementary Concept]
- 11-deoxy-3-des(hexopyranosyloxy)-6-O-methyl-11-(3-((3-methylphenylcarbamoyl)oxy)propylamino)-3-oxoerythromycin A 11-N,12-O-cyclic carbamate [MeSH Supplementary Concept]
- 11-deoxy-3-des(hexopyranosyloxy)-6-O-methyl-11-(3-((4-nitrophenylcarbamoyl)oxy)propylamino)-3-oxoerythromycin A 11-N,12-O-cyclic carbamate [MeSH Supplementary Concept]
- 12-O-methylerythromycin A [MeSH Supplementary Concept]
- 12-desmethyl-12-ethyl-6-deoxyerythronolide [MeSH Supplementary Concept]
- 13-cyclopentyl-13-desethyl-erythromycin B [MeSH Supplementary Concept]
- 15-azidoerythromycin A [MeSH Supplementary Concept]
- 15-fluoroerythromycin A [MeSH Supplementary Concept]
- 16-hydroxyclarithromycin [MeSH Supplementary Concept]
- 2'-desoxy-9-erythromycylamine [MeSH Supplementary Concept]
- 2,3-anhydro-5-O-desosaminyl--11-((3-(4-aminophenyl)-2-propenyl)hydrazo)-6-O-methylerythronolide A 11,12-carbamate [MeSH Supplementary Concept]
- 2,3-anhydro-5-O-desosaminyl-11-((3-(4-nitrophenyl)-2-propenyl)hydrazo)-6-O-methylerythronolide A 11,12-carbamate [MeSH Supplementary Concept]
- 2-desmethyl-2-methoxy-6-deoxyerythronolide B [MeSH Supplementary Concept]
- 2-oxo-12,16-dimethyl-3,5,10,14,15-icosanepentol hemiketal [MeSH Supplementary Concept]
- 5-O-desosaminyl-3-O-(3-pyridyl)acetyl-6-O-methylerythronolide A 11,12-cyclic carbamate [MeSH Supplementary Concept]
- 5-O-desosaminyl-9-dihydro-3O-(3-pyridyl)acetylerythronolide A 6,9-11,12-dicyclic carbonate [MeSH Supplementary Concept]
- 5-O-desosaminylerythronolide A oxime [MeSH Supplementary Concept]
- 6,12-dideoxyerythromycin A [MeSH Supplementary Concept]
- 6-(2''-hydroxy-3''-(2-(quinolin-6-ylamino)ethylamino)propoxy)-3-oxo-8a-aza-8a-homoerythromycin A [MeSH Supplementary Concept]
- 6-O-methylerythromycin A [MeSH Supplementary Concept]
- 6-O-methylerythromycin B [MeSH Supplementary Concept]
- 6-O-methylerythromycin D [MeSH Supplementary Concept]
- 6-deoxy-13-cyclopropyl-erythromycin B [MeSH Supplementary Concept]
- 6-deoxyerythromycin A [MeSH Supplementary Concept]
- 6-deoxyerythromycin D [MeSH Supplementary Concept]
- 6-deoxyerythronolide B [MeSH Supplementary Concept]
- 6-deoxysporeamicin A [MeSH Supplementary Concept]
- 7-hydroxy-6-demethyl-6-deoxyerythromycin D [MeSH Supplementary Concept]
- 8,9-anhydroerythromycin A 6,9-hemiketal [MeSH Supplementary Concept]
- 8,9-seco-8-oxoerythromycin-B-9-oic acid 6,9-lactone [MeSH Supplementary Concept]
- 8-deoxyankolide [MeSH Supplementary Concept]
- 8-hydroxyerythromycin A, cyclic carbonate [MeSH Supplementary Concept]
- 8a-aza-8a-homoerythromycin [MeSH Supplementary Concept]
- 9-N-(1-propyl)erythromyclamine [MeSH Supplementary Concept]
- 9-deoxo-12-deoxy-9,12-epoxyerythromycin [MeSH Supplementary Concept]
- 9-deoxo-4''-deoxy-3'-N--desmethyl-3'-N-ethanol-6,9-epoxyerythromycin A [MeSH Supplementary Concept]
- 9-deoxo-4''-deoxy-3'-N-desmethyl-3'-ethyl-6,9-epoxyerythromycin A [MeSH Supplementary Concept]
- 9-deoxo-9a-aza--9a-homoerythromicin A 6,9-cyclic imino ether [MeSH Supplementary Concept]
- 9-deoxy-9a-aza-9a-methyl-9a-homoerythromycin A [MeSH Supplementary Concept]
- 9-dihydro-12-O-methylerythromycin A [MeSH Supplementary Concept]
- 9-dihydroclarithromycin [MeSH Supplementary Concept]
- 9a-(3-(7-chloroquinolin-4-ylamino)propyl)-9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin A [MeSH Supplementary Concept]
- A 63075 [MeSH Supplementary Concept]
- CP 63956 [MeSH Supplementary Concept]
- EM 523 [MeSH Supplementary Concept]
- EM536 [MeSH Supplementary Concept]
- EM703 [MeSH Supplementary Concept]
- ER 42859 [MeSH Supplementary Concept]
- Idremcinal [MeSH Supplementary Concept]
- KC 11458 [MeSH Supplementary Concept]
- L 701677 [MeSH Supplementary Concept]
- L 708299 [MeSH Supplementary Concept]
- L 708365 [MeSH Supplementary Concept]
- LY 267108 [MeSH Supplementary Concept]
- MK 0641 [MeSH Supplementary Concept]
- N-methylerythromycin A [MeSH Supplementary Concept]
- SIPI-8294 [MeSH Supplementary Concept]
- TEA 0770 [MeSH Supplementary Concept]
- adimicin [MeSH Supplementary Concept]
- alemcinal [MeSH Supplementary Concept]
- anhydroerythromycin A [MeSH Supplementary Concept]
- benzoyl peroxide, erythromycin drug combination [MeSH Supplementary Concept]
- berythromycin [MeSH Supplementary Concept]
- darcanolide [MeSH Supplementary Concept]
- de-(N-methyl)-8,9-anhydroerythromycin A 6,9-hemicetal [MeSH Supplementary Concept]
- dirithromycin [MeSH Supplementary Concept]
- erythralosamine [MeSH Supplementary Concept]
- erythralosamine-2',3-diacetate [MeSH Supplementary Concept]
- erythromycin 2'-acetate [MeSH Supplementary Concept]
- erythromycin 2'-dodecyl glutaramide [MeSH Supplementary Concept]
- erythromycin A 9-oxime desosaminehydrazinium salt [MeSH Supplementary Concept]
- erythromycin A cyclic 11,12-carbonate [MeSH Supplementary Concept]
- erythromycin A cyclic carbonate L-aspartate [MeSH Supplementary Concept]
- erythromycin A isoxazoline [MeSH Supplementary Concept]
- erythromycin A methoxime [MeSH Supplementary Concept]
- erythromycin A oxime 11,12-carbonate [MeSH Supplementary Concept]
- erythromycin B 2'-ethyl succinate [MeSH Supplementary Concept]
- erythromycin B enol ether 2'-ethyl succinate [MeSH Supplementary Concept]
- erythromycin B enol ethyl ether [MeSH Supplementary Concept]
- erythromycin E [MeSH Supplementary Concept]
- erythromycin G [MeSH Supplementary Concept]
- erythromycin aspartate [MeSH Supplementary Concept]
- erythromycin glucoheptonate [MeSH Supplementary Concept]
- erythromycin lactobionate [MeSH Supplementary Concept]
- erythromycin nalidixate [MeSH Supplementary Concept]
- erythromycin oxime [MeSH Supplementary Concept]
- erythromycin propionate [MeSH Supplementary Concept]
- erythromycin propionate-N-acetylcysteinate [MeSH Supplementary Concept]
- erythromycin stearate [MeSH Supplementary Concept]
- erythromycin thiocyanate [MeSH Supplementary Concept]
- erythromycin(OSn(tBu)2)2O [MeSH Supplementary Concept]
- erythromycin, ammonium bituminosulfonate drug combination [MeSH Supplementary Concept]
- erythromycin, zinc acetate drug combination [MeSH Supplementary Concept]
- erythromyclamine [MeSH Supplementary Concept]
- erythronolide A [MeSH Supplementary Concept]
- erythronolide B [MeSH Supplementary Concept]
- erythronolide H [MeSH Supplementary Concept]
- erythronolide I [MeSH Supplementary Concept]
- flurithromycin [MeSH Supplementary Concept]
- kujimycin A [MeSH Supplementary Concept]
- kujimycin B [MeSH Supplementary Concept]
- mitemcinal [MeSH Supplementary Concept]
- propionyl erythromycin mercaptosuccinate [MeSH Supplementary Concept]
- protegentin [MeSH Supplementary Concept]
- sporeamicin A [MeSH Supplementary Concept]
- sporeamicin B [MeSH Supplementary Concept]
- sporeamicin C [MeSH Supplementary Concept]
- technetium tc 99m erthyromycin lactobionate [MeSH Supplementary Concept]
- technetium tc 99m erythromycin [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Erythromycin [NCIt concept]
- Erythromycin [LOINC component]
- Erythromycin (substance) [SNOMED CT concept]
- Product containing erythromycin (medicinal product) [SNOMED CT concept]
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin [Substance BNPC]
- erythromycin, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- Erythromycin Phosphate [NCIt concept]
- Erythromycin lactate [SMS substance]
- Erythromycin phosphate (substance) [SNOMED CT concept]
- Ilotycin [ICD-11 Extension code]
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin [ATC Code]
- erythromycin phosphate [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients